Kevin Gardner, MD, PhD
Columbia University Medical Center
Elizabeth Whitley, DVM, PhD
MD Anderson Cancer Center
Session Description: Tapping into the vast amount of information stored in the genome holds great promise for the development of targeted, patient-specific clinical decision-making. In this symposium, we highlight several vanguard studies that support developing knowledge-based therapeutics and preventions for cancer. The first presentation of this symposium will focus on the use of genomic technologies and bioinformatics analysis to determine relationships between germ-line and somatic alterations in populations and cancer risk and progression. The second presentation will delve into hereditary differences in Vitamin D metabolism and prostate cancer aggressiveness and mortality. The third presentation will describe genetic and environmental factors among Latina women that affect the risk of developing breast cancer or of having progressive disease.